Ajay Major: Our multicenter study of checkpoint inhibitor outcomes in the post-CAR-T setting is now published online in full at Blood Advances.

As Ajay Major stated on LinkedIn:

“Our multicenter study of checkpoint inhibitor outcomes in the post-CAR-T setting is now published online in full at Blood Advances. Response rates and survival are poor with these agents and novel approaches (such as bispecifics) are needed. Many thanks to my mentor Dr. Kline and all of our collaborators for bringing this manuscript to fruition.”

For the article click here

Source: Ajay Major / LinkedIn